Rafferty Asset Management, LLC Eagle Pharmaceuticals, Inc. Transaction History

Rafferty Asset Management, LLC

$28.9 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$24.98 - $39.77 $31,774 - $50,587	1,272 Added 2.22%	58,576 $1.71 Million
Q3 2022 Nov 14, 2022	BUY	$26.42 - $47.12 $963,669 - $1.72 Million	36,475 Added 175.12%	57,304 $1.51 Million
Q2 2022 Aug 12, 2022	SELL	$41.26 - $51.35 $331,936 - $413,110	-8,045 Reduced 27.86%	20,829 $925,000
Q1 2022 May 13, 2022	SELL	$44.58 - $52.6 $152,508 - $179,944	-3,421 Reduced 10.59%	28,874 $1.43 Million
Q4 2021 Feb 10, 2022	BUY	$45.82 - $56.9 $603,770 - $749,771	13,177 Added 68.92%	32,295 $1.64 Million
Q3 2021 Nov 10, 2021	SELL	$43.79 - $55.78 $93,535 - $119,146	-2,136 Reduced 10.05%	19,118 $1.07 Million
Q2 2021 Aug 10, 2021	SELL	$36.86 - $44.5 $366,941 - $442,997	-9,955 Reduced 31.9%	21,254 $910,000
Q1 2021 May 10, 2021	BUY	$40.32 - $50.97 $955,463 - $1.21 Million	23,697 Added 315.46%	31,209 $1.3 Million
Q4 2020 Feb 10, 2021	SELL	$41.72 - $51.34 $493,464 - $607,249	-11,828 Reduced 61.16%	7,512 $350,000
Q3 2020 Nov 13, 2020	BUY	$37.02 - $51.28 $395,817 - $548,285	10,692 Added 123.64%	19,340 $822,000
Q2 2020 Aug 07, 2020	BUY	$43.24 - $55.02 $373,939 - $475,812	8,648 New	8,648 $415,000
Q1 2020 May 15, 2020	SELL	$34.37 - $60.07 $554,869 - $969,770	-16,144 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$54.32 - $64.31 $426,846 - $505,347	-7,858 Reduced 32.74%	16,144 $970,000
Q3 2019 Nov 14, 2019	SELL	$53.25 - $59.98 $549,753 - $619,233	-10,324 Reduced 30.08%	24,002 $1.36 Million
Q2 2019 Aug 09, 2019	BUY	$46.61 - $58.45 $365,702 - $458,598	7,846 Added 29.63%	34,326 $1.91 Million
Q1 2019 May 15, 2019	BUY	$38.66 - $51.82 $1.02 Million - $1.37 Million	26,480 New	26,480 $1.34 Million
Q4 2017 Feb 14, 2018	SELL	$49.6 - $60.87 $644,056 - $790,396	-12,985 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$46.62 - $60.36 $605,360 - $783,774	12,985	12,985 $774,000

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account